PLGA Multiplex Membrane Platform for Disease Modelling and Testing of Therapeutic Compounds

• Main Authors: Antonella Piscioneri, Sabrina Morelli, Enrico Drioli, Loredana De Bartolo
• Format: Article
• Language: English
• Published: MDPI AG 2021-02-01
• Series: Membranes
• Subjects: disease modelling; trans-crocetin neuroprotection; PLGA membrane; membrane systems
• Online Access: https://www.mdpi.com/2077-0375/11/2/112

A proper validation of an engineered brain microenvironment requires a trade of between the complexity of a cellular construct within the in vitro platform and the simple implementation of the investigational tool. The present work aims to accomplish this challenging balance by setting up an innovative membrane platform that represents a good compromise between a proper mimicked brain tissue analogue combined with an easily accessible and implemented membrane system. Another key aspect of the in vitro modelling disease is the identification of a precise phenotypic onset as a definite hallmark of the pathology that needs to be recapitulated within the implemented membrane system. On the basis of these assumptions, we propose a multiplex membrane system in which the recapitulation of specific neuro-pathological onsets related to Alzheimer’s disease pathologies, namely oxidative stress and β-amyloid_1–42 toxicity, allowed us to test the neuroprotective effects of trans-crocetin on damaged neurons. The proposed multiplex membrane platform is therefore quite a versatile tool that allows the integration of neuronal pathological events in combination with the testing of new molecules. The present paper explores the use of this alternative methodology, which, relying on membrane technology approach, allows us to study the basic physiological and pathological behaviour of differentiated neuronal cells, as well as their changing behaviour, in response to new potential therapeutic treatment.